rs4344931

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000030.3(AGXT):​c.*289A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.696 in 532,554 control chromosomes in the GnomAD database, including 130,757 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.73 ( 40986 hom., cov: 32)
Exomes 𝑓: 0.68 ( 89771 hom. )

Consequence

AGXT
NM_000030.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:3

Conservation

PhyloP100: -3.97

Publications

23 publications found
Variant links:
Genes affected
AGXT (HGNC:341): (alanine--glyoxylate aminotransferase) This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008]
AGXT Gene-Disease associations (from GenCC):
  • alanine glyoxylate aminotransferase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • primary hyperoxaluria type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 2-240879110-A-C is Benign according to our data. Variant chr2-240879110-A-C is described in ClinVar as Benign. ClinVar VariationId is 204064.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.844 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGXTNM_000030.3 linkc.*289A>C 3_prime_UTR_variant Exon 11 of 11 ENST00000307503.4 NP_000021.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGXTENST00000307503.4 linkc.*289A>C 3_prime_UTR_variant Exon 11 of 11 1 NM_000030.3 ENSP00000302620.3
AGXTENST00000470255.1 linkn.1246A>C non_coding_transcript_exon_variant Exon 3 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.728
AC:
110609
AN:
151960
Hom.:
40945
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.851
Gnomad AMI
AF:
0.699
Gnomad AMR
AF:
0.592
Gnomad ASJ
AF:
0.593
Gnomad EAS
AF:
0.737
Gnomad SAS
AF:
0.534
Gnomad FIN
AF:
0.745
Gnomad MID
AF:
0.617
Gnomad NFE
AF:
0.702
Gnomad OTH
AF:
0.696
GnomAD4 exome
AF:
0.683
AC:
259740
AN:
380478
Hom.:
89771
Cov.:
0
AF XY:
0.673
AC XY:
134824
AN XY:
200188
show subpopulations
African (AFR)
AF:
0.849
AC:
9337
AN:
10998
American (AMR)
AF:
0.558
AC:
9083
AN:
16290
Ashkenazi Jewish (ASJ)
AF:
0.606
AC:
7094
AN:
11698
East Asian (EAS)
AF:
0.723
AC:
18205
AN:
25192
South Asian (SAS)
AF:
0.544
AC:
24162
AN:
44452
European-Finnish (FIN)
AF:
0.738
AC:
16849
AN:
22832
Middle Eastern (MID)
AF:
0.619
AC:
1007
AN:
1628
European-Non Finnish (NFE)
AF:
0.705
AC:
158817
AN:
225390
Other (OTH)
AF:
0.690
AC:
15186
AN:
21998
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
3901
7803
11704
15606
19507
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
718
1436
2154
2872
3590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.728
AC:
110697
AN:
152076
Hom.:
40986
Cov.:
32
AF XY:
0.723
AC XY:
53712
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.852
AC:
35346
AN:
41504
American (AMR)
AF:
0.592
AC:
9048
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.593
AC:
2059
AN:
3472
East Asian (EAS)
AF:
0.736
AC:
3795
AN:
5154
South Asian (SAS)
AF:
0.534
AC:
2570
AN:
4814
European-Finnish (FIN)
AF:
0.745
AC:
7895
AN:
10594
Middle Eastern (MID)
AF:
0.623
AC:
182
AN:
292
European-Non Finnish (NFE)
AF:
0.702
AC:
47714
AN:
67948
Other (OTH)
AF:
0.690
AC:
1452
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1518
3035
4553
6070
7588
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
830
1660
2490
3320
4150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.705
Hom.:
76812
Bravo
AF:
0.724
Asia WGS
AF:
0.653
AC:
2276
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary hyperoxaluria, type I Uncertain:1Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 27, 2014
Clinical Biochemistry Laboratory, Health Services Laboratory
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

not provided Benign:2
Aug 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.16
DANN
Benign
0.47
PhyloP100
-4.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4344931; hg19: chr2-241818527; API